Protective efficacy of high-passage avian pneumovirus (APV/MN/turkey/1-a/97) in turkeys

Avian Diseases

Volumn 45, Issue 3, 2001, Pages 593-597

  Gulati, B R ^a   Patnayak, D P ^a   Sheikh, A M ^a   Poss, P E ^a   Goyal, S M ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL CULTURE; AVIAN PNEUMOVIRUS; CHICKEN; DAY LENGTH; EMBRYO CULTURE; ENZYME LINKED IMMUNOSORBENT ASSAY; FIBROBLAST; IMMUNITY; INOCULATION; POPULATION DENSITY; TURKEY; UNITED STATES; VIRUS INFECTION; VIRUS INFECTIVITY; VIRUS VIRULENCE;

EID: 0034808638     PISSN: 00052086     EISSN: None     Source Type: Journal    
DOI: 10.2307/1592899     Document Type: Article

References (17)

1. A modified enzyme-linked immunosorbent assay for the detection of avian pneumovirus antibodies
2. Rational design of live-attenuated recombinant vaccine virus for human respiratory syncytial virus by reverse genetics
3. An experimental turkey rhinotracheitis (TRT) infection in breeding turkeys and the prevention of its clinical effects using live-attenuated and inactivated TRT vaccines
4. Isolation of avian pneumovirus from an outbreak of respiratory illness in Minnesota turkeys
5. Avian pneumovirus ELISA: Determining antibody titers from a single serum dilution
6. Development of a highly sensitive and specific enzyme-linked immunosorbent assay based on recombinant matrix protein for detection of avian pneumovirus antibodies
7. Avian pneumovirus infection in Minnesota turkeys: Experimental reproduction of the disease
8. Evaluation of two live, cold-passaged, temperature-sensitive respiratory syncytial virus vaccines in chimpanzees and in human adults, infants and children
9. Report of the committee on transmissible diseases of poultry and other avian species
10. Incidence of avian pneumovirus
11. Current approaches to the development of vaccines effective against parainfluenza and respiratory syncytial viruses
12. Demonstration of a virulent subpopulation in a prototype live attenuated turkey rhinotracheitis vaccine
13. Experimental and serologic observation on avian pneumovirus (APV/turkey/Colorado/97) infection in turkeys
14. Matrix protein gene nucleotide and predicted amino acid sequence demonstrate that the first U.S. avian pneumovirus isolate is distinct from European strains
15. Fusion protein predicted amino acid sequence of the first U.S. avian pneumovirus isolate and lack of heterogeneity among other U.S. isolates
16. Specific detection of avian pneumovirus U.S.- isolates by RT-PCR
17. Development of a live attenuated vaccine against turkey rhinotracheitis